TRGNF
Price:
$0.85
Market Cap:
$108.44M
Transgene S.A. is a biotechnology company dedicated to the creation and advancement of therapeutic vaccines and oncolytic viruses. Its core mission is to develop innovative treatments for both cancer and various infectious diseases. The company's drug development pipeline includes several promising candidates: TG4050, a therapeutic vaccine, is currently in early-stage Phase I clinical trials for its potential use against ovarian cancer and certain types of HPV-negative head and neck cancers. TG4001, another therapeutic vaccine, has progressed to Phase II clinical trials, where it is being evaluated for the treatment of HPV-positive cancers. TG6002, an oncolytic virus, is undergoing Phase I/I...[Read more]
Industry
Biotechnology
IPO Date
2021-01-08
Stock Exchange
OTC
Ticker
TRGNF
According to Transgene S.A.’s latest financial reports and current stock price. The company's current ROE is -63.53%. This represents a change of -108.25% compared to the average of 770.38% of the last 4 quarters.
The mean historical ROE of Transgene S.A. over the last ten years is -72.63%. The current -63.53% ROE has changed -12.53% with respect to the historical average. Over the past ten years (40 quarters), TRGNF's ROE was at its highest in in the June 2024 quarter at 2.68%. The ROE was at its lowest in in the December 2024 quarter at -115.01%.
Average
-72.63%
Median
-45.46%
Minimum
-223.43%
Maximum
21.87%
Discovering the peaks and valleys of Transgene S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 191.31%
Maximum Annual ROE = 21.87%
Minimum Annual Increase = -230.88%
Minimum Annual ROE = -223.43%
| Year | ROE | Change |
|---|---|---|
| 2025 | -30.82% | -86.20% |
| 2024 | -223.43% | 56.23% |
| 2023 | -143.02% | 64.95% |
| 2022 | -86.70% | 191.31% |
| 2021 | -29.76% | -18.94% |
| 2020 | -36.72% | 28.28% |
| 2019 | -28.62% | -230.88% |
| 2018 | 21.87% | -119.03% |
| 2017 | -114.90% | 111.97% |
| 2016 | -54.21% | -68.97% |
The current ROE of Transgene S.A. (TRGNF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-132.43%
5-year avg
-102.75%
10-year avg
-72.63%
Transgene S.A.’s ROE is less than Hansa Biopharma AB (publ) (201.60%), greater than Silence Therapeutics plc (-121.71%), greater than Cellectis S.A. (-80.61%), greater than Immutep Limited (-69.20%), greater than Genfit S.A. (-596.44%), greater than hVIVO plc (-14.65%), less than Santhera Pharmaceuticals Holding AG (684.83%), greater than Mayne Pharma Group Limited (-23.02%), less than Probi AB (publ) (1.21%), greater than Oryzon Genomics S.A. (-2.03%),
| Company | ROE | Market cap |
|---|---|---|
| 201.60% | $245.80M | |
| -121.71% | $313.17M | |
| -80.61% | $251.93M | |
| -69.20% | $73.69M | |
| -596.44% | $499.80M | |
| -14.65% | $75.45M | |
| 684.83% | $344.83M | |
| -23.02% | $134.06M | |
| 1.21% | $286.93M | |
| -2.03% | $282.54M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Transgene S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Transgene S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Transgene S.A.'s ROE?
How is the ROE calculated for Transgene S.A. (TRGNF)?
What is the highest ROE for Transgene S.A. (TRGNF)?
What is the 3-year average ROE for Transgene S.A. (TRGNF)?
What is the 5-year average ROE for Transgene S.A. (TRGNF)?
How does the current ROE for Transgene S.A. (TRGNF) compare to its historical average?